Nuclein Closes $14M in Series B Funding

29 Mar, 2021

Nuclein Closes $14M in Series B Funding
Photo by Koukichi Takahashi on Unsplash

– Nuclein, a developer of a fully integrated care management platform for multiple sclerosis as well as a full range of neurodegenerative diseases, has closed a $14m Series B funding round.
– The round was led by Trinity Private Equity Group (TPEG), a Southlake, Texas-based private equity firm.

Biotechnology Medical Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: